{"id":113509,"date":"2021-05-04T12:04:38","date_gmt":"2021-05-04T12:04:38","guid":{"rendered":"https:\/\/fin2me.com\/?p=113509"},"modified":"2021-05-04T12:04:38","modified_gmt":"2021-05-04T12:04:38","slug":"stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more","status":"publish","type":"post","link":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/","title":{"rendered":"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more"},"content":{"rendered":"

Take a look at some of the biggest movers in the premarket:<\/em><\/p>\n

CVS Health (CVS) \u2013 The drug store and pharmacy benefits management company earned $2.04 per share in the first quarter, above the consensus estimate of $1.72 a share. Revenue also came in above Wall Street forecasts. CVS saw higher sales at its stores, with customer traffic spurred by Covid-19 vaccination visits. CVS also raised its full-year forecast, and its shares rose 3% in the premarket.<\/p>\n

iRobot (IRBT) \u2013 iRobot earned 41 cents per share during the first quarter, compared to a consensus estimate of 9 cents a share. The maker of the Roomba robotic vacuum's revenue exceeded estimates as well, however the stock tumbled 8.6% in the premarket on concerns about shipping and component costs.<\/p>\n

Pfizer (PFE) \u2013 The drugmaker beat estimates by 16 cents a share, with quarterly profit of 93 cents per share. Revenue also came in above forecasts and the company raised its full-year guidance as sales of its Covid-19 vaccine continue to be stronger than expected. Additionally, the Food and Drug Administration is set to authorize the vaccine for use in adolescents aged 12-15, according to federal officials familiar with the plan who spoke to The New York Times. Pfizer shares added 1.3% in premarket trading.<\/p>\n

Vaxart (VXRT) \u2013 Vaxart surged 18.6% in premarket trading after it reported positive results in a phase 1 trial of its oral Covid-19 vaccine. Vaxart said the vaccine could be just as effective as the injected vaccines developed by Pfizer and Moderna (MRNA).<\/p>\n

Under Armour (UAA) \u2013 The athletic apparel maker's stock climbed 2.8% in premarket action after it reported first-quarter profit of 16 cents per share, well above the 3 cents a share consensus estimate. Revenue also topped analysts' forecasts and Under Armour raised its full-year outlook as reopening markets spur demand for shoes and apparel. Separately, the company agreed to pay $9 million to settle a Securities and Exchange Commission probe into its accounting.<\/p>\n

DuPont (DD) \u2013 The industrial materials maker reported quarterly profit of 91 cents per share, 15 cents a share above estimates. Revenue also topped analysts' forecasts. DuPont is seeing strong demand for its products from semiconductor makers as well as automobile markets, and the company raised its full-year profit and revenue forecast.<\/p>\n

XPO Logistics (XPO) \u2013 XPO reported quarterly earnings of $1.46 per share, well above the consensus estimate of 97 cents a share. The transportation company's revenue was also above Wall Street forecasts, reaching record levels in sharp contrast to usual seasonal trends. XPO also raised its full-year forecast, but its shares lost 1.2% in premarket action.<\/p>\n

Avis Budget (CAR) \u2013 Avis Budget lost 46 cents per share for the first quarter, smaller than the loss of $2.16 a share predicted by analysts. The car rental company's revenue beat Wall Street forecasts as well amid a jump in demand and more solid pricing for car rentals. The stock fell 1.4% in premarket action despite the upbeat results.<\/p>\n

Qiagen (QGEN) \u2013 Qiagen reported better-than-expected earnings and sales for its latest quarter, as the genetic testing company saw increasing demand for non-coronavirus products as well as strength in its Covid-19 testing business.<\/p>\n

SmileDirectClub (SDC) \u2013 SmileDirectClub said its current-quarter sales will be hurt by an April cyberattack, costing it between $10 million and $15 million. The maker of teeth-straightening systems said it successfully blocked the attack and restored its systems to normal. The stock lost 9.2% in the premarket. (Disclosure: NBC Nightly News investigated SmileDirectClub's customer complaints in February. The company accused NBCUniversal of publishing false information about the company and is seeking $2.85 billion for defamation.)<\/p>\n

Domtar (UFS) \u2013 Domtar shares soared 16.1% in premarket action following a Bloomberg report that said Canada's Paper Excellence is exploring a deal to buy its U.S.-based paper and packaging rival. A deal could value Domtar in the mid-$50 per share range, compared to Monday's close of $40.52 a share.<\/p>\n

Source: Read Full Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Take a look at some of the biggest movers in the premarket: CVS Health (CVS) \u2013 The drug store and pharmacy benefits management company earned […]<\/p>\n","protected":false},"author":3,"featured_media":113508,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"yoast_head":"\nStocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me\" \/>\n<meta property=\"og:description\" content=\"Take a look at some of the biggest movers in the premarket: CVS Health (CVS) \u2013 The drug store and pharmacy benefits management company earned [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/\" \/>\n<meta property=\"og:site_name\" content=\"Fin2me\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-04T12:04:38+00:00\" \/>\n<meta name=\"author\" content=\"Mark\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/05\/Stocks-making-the-biggest-moves-in-the-premarket-CVS-Health-iRobot-Vaxart-more.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mark\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/\",\"url\":\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/\",\"name\":\"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me\",\"isPartOf\":{\"@id\":\"https:\/\/fin2me.com\/#website\"},\"datePublished\":\"2021-05-04T12:04:38+00:00\",\"dateModified\":\"2021-05-04T12:04:38+00:00\",\"author\":{\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\"},\"breadcrumb\":{\"@id\":\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fin2me.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Markets\",\"item\":\"https:\/\/fin2me.com\/category\/markets\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fin2me.com\/#website\",\"url\":\"https:\/\/fin2me.com\/\",\"name\":\"Fin2me\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fin2me.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a\",\"name\":\"Mark\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fin2me.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g\",\"caption\":\"Mark\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/","og_locale":"en_US","og_type":"article","og_title":"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me","og_description":"Take a look at some of the biggest movers in the premarket: CVS Health (CVS) \u2013 The drug store and pharmacy benefits management company earned [...]","og_url":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/","og_site_name":"Fin2me","article_published_time":"2021-05-04T12:04:38+00:00","author":"Mark","twitter_card":"summary_large_image","twitter_image":"https:\/\/fin2me.com\/wp-content\/uploads\/2021\/05\/Stocks-making-the-biggest-moves-in-the-premarket-CVS-Health-iRobot-Vaxart-more.jpg","twitter_misc":{"Written by":"Mark","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/","url":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/","name":"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more - Fin2me","isPartOf":{"@id":"https:\/\/fin2me.com\/#website"},"datePublished":"2021-05-04T12:04:38+00:00","dateModified":"2021-05-04T12:04:38+00:00","author":{"@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a"},"breadcrumb":{"@id":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fin2me.com\/markets\/stocks-making-the-biggest-moves-in-the-premarket-cvs-health-irobot-vaxart-more\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fin2me.com\/"},{"@type":"ListItem","position":2,"name":"Markets","item":"https:\/\/fin2me.com\/category\/markets\/"},{"@type":"ListItem","position":3,"name":"Stocks making the biggest moves in the premarket: CVS Health, iRobot, Vaxart & more"}]},{"@type":"WebSite","@id":"https:\/\/fin2me.com\/#website","url":"https:\/\/fin2me.com\/","name":"Fin2me","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fin2me.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/fin2me.com\/#\/schema\/person\/ad0e9920e03d3b41c7ad02a18375d76a","name":"Mark","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fin2me.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/39b72719fb75a2d3c7d7695026648602?s=96&d=mm&r=g","caption":"Mark"}}]}},"_links":{"self":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/113509"}],"collection":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/comments?post=113509"}],"version-history":[{"count":0,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/posts\/113509\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media\/113508"}],"wp:attachment":[{"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/media?parent=113509"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/categories?post=113509"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fin2me.com\/wp-json\/wp\/v2\/tags?post=113509"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}